NEW YORK, NY / ACCESS Newswire / September 17, 2025 / Every once in a while, an industry has its thunderbolt moment.
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
NEW YORK, NY / ACCESS Newswire / September 17, 2025 / Every great industry eventually faces the same showdown. Not over who builds the best technology or who moves the fastest, but over who writes the ...
Prestigious three-year multicenter clinical trial confirms revolutionary implantable lens technology achieves exceptional visual outcomes with minimal complications Dr. Jason P. Brinton of Brinton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results